GlobalData on MSN2d
FDA approves MSD’s KEYTRUDA as first-line MPM treatment
The approval for the KEYTRUDA regimen is supported by results from the Phase II/III IND.227/KEYNOTE-483 trial.
WDRB3d
Kentucky lawmaker calls out MSD for salary increases after recent rate hikes
A Kentucky state lawmaker has taken to social media to call out what he believes are excessive salaries and pay raises for ...
Daiichi Sankyo and MSD’s ADC improves progression-free survival in NSCLC trial
In the trial, most interstitial lung disease events were observed to be low grade, with two grade 5 ILD events being reported ...
WAVE33d
Legislator Jason Nemes questions Louisville MSD pay raises
LOUISVILLE, Ky. (WAVE) - Louisville’s Metropolitan Sewer District is under scrutiny over recent salary increases. MSD’s CEO ...
Keytruda keys in on survival: Promising results in high-risk early-stage TNBC from KEYNOTE-522
In 2021, the FDA criticised MSD for relying on an early endpoint to seek approval for Keytruda in early-stage TNBC.
The Daily Republic5d
Community unites to offer free senior photos for Mitchell High students
Mitchell School District's Caring Closet partners with local photographers to ensure every graduating senior has a chance to ...